EIM
STDY

Essex Investment Management’s SteadyMed Ltd STDY Stock Holding History

Essex Investment Management’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-256,790
Closed -$1.16M – 457
2018
Q2 		$1.16M Buy
256,790
+286
+0.1% +$1.17K 0.14% 211
2018
Q1 		$834K Sell
256,504
-19,260
-7% -$63.7K 0.11% 232
2017
Q4 		$1.02M Buy
275,764
+247,343
+870% +$799K 0.13% 213
2017
Q3 		$95K Buy
+28,421
New +$151K 0.01% 349

Other funds holding STDY

AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM

Essex Investment Management's STDY Position: Q3 2018 in Review

Essex Investment Management sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 256,790 shares — an estimated $1.16M sold.

Essex Investment Management first reported a position in STDY in Q3 2017 and held it in 4 quarters. The position peaked at $1.16M in Q2 2018. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

  • Essex Investment Management reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
  • Essex Investment Management sold 256,790 SteadyMed Ltd shares in Q3 2018, an estimated $1.16M.
  • Essex Investment Management first reported a position in SteadyMed Ltd in Q3 2017 and held it in 4 quarters.
  • Essex Investment Management's SteadyMed Ltd position peaked at $1.16M in Q2 2018.
  • 5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Essex Investment Management's 13F filing for Q3 2018, filed 16 Oct 2018.